Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of the combination of
cytotoxic chemotherapy (Oxaliplatin and 5Fu) with bevacizumab concomitantly with radiotherapy
as neoadjuvant treatment for patients with locally advanced but resectable rectal
adenocarcinoma.